MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 88 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 3.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,986 | -15.0% | 25,961 | +14.7% | 0.00% | – |
| Q2 2023 | $245,871 | +25.4% | 22,640 | +7.9% | 0.00% | – |
| Q1 2022 | $196,000 | -29.2% | 20,984 | -10.2% | 0.00% | – |
| Q4 2021 | $277,000 | +9.5% | 23,362 | +5.3% | 0.00% | – |
| Q3 2021 | $253,000 | -38.3% | 22,180 | -3.0% | 0.00% | – |
| Q2 2021 | $410,000 | +37.6% | 22,864 | +18.7% | 0.00% | – |
| Q1 2021 | $298,000 | +32.4% | 19,261 | +4.4% | 0.00% | – |
| Q4 2020 | $225,000 | +24.3% | 18,457 | +31.4% | 0.00% | – |
| Q3 2020 | $181,000 | – | 14,048 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |